The Impact of the COVID-19 Pandemic on Respiratory Syncytial Virus Infection: A Narrative Review

References

• Nam HH, Ison MG. Respiratory syncytial virus infection in adults. BMJ. 2019;366:l5021. doi:10.1136/bmj.l5021
   PubMedGoogle Scholar
• Tin Tin Htar M, Yerramalla MS, Moisi JC, Swerdlow DL. The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis. Epidemiol Infect. 2020;148:e48. doi:10.1017/S0950268820000400
   PubMed Web of Science ®Google Scholar
• Gomez GB, Mahe C, Chaves SS. Uncertain effects of the pandemic on respiratory viruses. Science. 2021;372(6546):1043–1044. doi:10.1126/science.abh3986
   PubMed Web of Science ®Google Scholar
• Haynes AK, Manangan AP, Iwane MK, et al. Respiratory syncytial virus circulation in seven countries with Global Disease Detection Regional Centers. J Infect Dis. 2013;208(Suppl 3):S246–54. doi:10.1093/infdis/jit515
   PubMedGoogle Scholar
• Coutinho Baldoto Gava Chakr V. Which should we fear more in preschoolers and infants: SARS-CoV-2 or respiratory syncytial virus? Postgrad Med J. 2022;98(1161):e7. doi:10.1136/postgradmedj-2021-141012
   PubMed Web of Science ®Google Scholar
• World Health Organization. Considerations for Implementing and Adjusting Public Health and Social Measures in the Context of COVID-19: Interim Guidance, 14 June 2021. 2021. Available from: https://apps.who.int/iris/handle/10665/341811. Accessed January 18, 2023.
   Google Scholar
• Achangwa C, Park H, Ryu S, Lee MS. Collateral Impact of Public Health and Social Measures on Respiratory Virus Activity during the COVID-19 Pandemic 2020-2021. Viruses. 2022;14(5):May. doi:10.3390/v14051071
   Web of Science ®Google Scholar
• Weinberger Opek M, Yeshayahu Y, Glatman-Freedman A, Kaufman Z, Sorek N, Brosh-Nissimov T. Delayed respiratory syncytial virus epidemic in children after relaxation of COVID-19 physical distancing measures, Ashdod, Israel, 2021. Euro Surveill. 2021;26(29). doi:10.2807/1560-7917.ES.2021.26.29.2100706
   PubMedGoogle Scholar
• Williams TC, Sinha I, Barr IG, Zambon M. Transmission of paediatric respiratory syncytial virus and influenza in the wake of the COVID-19 pandemic. Euro Surveill. 2021;26(29). doi:10.2807/1560-7917.ES.2021.26.29.2100186
   Google Scholar
• Fourgeaud J, Toubiana J, Chappuy H, et al. Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France. Eur J Clin Microbiol Infect Dis. 2021;40(11):2389–2395. doi:10.1007/s10096-021-04323-1
   PubMed Web of Science ®Google Scholar
• Kim S, Williams TC, Viboud C, Campbell H, Chen J, Spiro DJ. RSV genomic diversity and the development of a globally effective RSV intervention. Vaccine. 2021;39(21):2811–2820. doi:10.1016/j.vaccine.2021.03.096
   PubMed Web of Science ®Google Scholar
• Mosscrop LG, Williams TC, Tregoning JS. Respiratory syncytial virus after the SARS-CoV-2 pandemic - what next? Nat Rev Immunol. 2022;22(10):589–590. doi:10.1038/s41577-022-00764-7
   PubMed Web of Science ®Google Scholar
• Giannekas M. MapChart. Available from: https://www.mapchart.net/.
   Google Scholar
• Uhteg K, Amadi A, Forman M, Mostafa HH. Circulation of Non-SARS-CoV-2 Respiratory Pathogens and Coinfection with SARS-CoV-2 Amid the COVID-19 Pandemic. Open Forum Infect Dis. 2022;9(3):ofab618. doi:10.1093/ofid/ofab618
   PubMed Web of Science ®Google Scholar
• Yuan H, Yeung A, Yang W. Interactions among common non-SARS-CoV-2 respiratory viruses and influence of the COVID-19 pandemic on their circulation in New York City. Influenza Other Respir Viruses. 2022;16(4):653–661. doi:10.1111/irv.12976
   PubMedGoogle Scholar
• Halabi KC, Saiman L, Zachariah P. The Epidemiology of Respiratory Syncytial Virus in New York City during the Coronavirus Disease-2019 Pandemic Compared with Previous Years. J Pediatr. 2022;242:242–244 e1. doi:10.1016/j.jpeds.2021.10.057
   PubMed Web of Science ®Google Scholar
• Nolen LD, Seeman S, Bruden D, et al. Impact of Social Distancing and Travel Restrictions on Non–Coronavirus Disease 2019 (Non–COVID-19) Respiratory Hospital Admissions in Young Children in Rural Alaska. Clin Infect Dis. 2020;72(12):2196–2198. doi:10.1093/cid/ciaa1328
   Web of Science ®Google Scholar
• Groves HE, Piche-Renaud PP, Peci A, et al. The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: a population-based study. Lancet Reg Health Am. 2021;1:100015. doi:10.1016/j.lana.2021.100015
   PubMedGoogle Scholar
• Doroshenko A, Lee N, MacDonald C, Zelyas N, Asadi L, Kanji JN. Decline of Influenza and Respiratory Viruses With COVID-19 Public Health Measures: Alberta, Canada. Mayo Clin Proc. 2021;96(12):3042–3052. doi:10.1016/j.mayocp.2021.09.004
   PubMed Web of Science ®Google Scholar
• Varela FH, Scotta MC, Polese-Bonatto M, et al. Absence of detection of RSV and influenza during the COVID-19 pandemic in a Brazilian cohort: likely role of lower transmission in the community. J Glob Health. 2021;11:05007. doi:10.7189/jogh.11.05007
   PubMed Web of Science ®Google Scholar
• Quandelacy TM, Adams LE, Munoz J, et al. Reduced spread of influenza and other respiratory viral infections during the COVID-19 pandemic in southern Puerto Rico. PLoS One. 2022;17(4):e0266095. doi:10.1371/journal.pone.0266095
   PubMed Web of Science ®Google Scholar
• Redlberger-Fritz M, Kundi M, Aberle SW, Puchhammer-Stockl E. Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria. J Clin Virol. 2021;137:104795. doi:10.1016/j.jcv.2021.104795
   PubMed Web of Science ®Google Scholar
• Bardsley M, Morbey RA, Hughes HE, et al. Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study. Lancet Infect Dis. 2014;1:548. doi:10.1016/S1473-3099(22)00525-4
   Google Scholar
• Van Brusselen D, De Troeyer K, Ter Haar E, et al. Bronchiolitis in COVID-19 times: a nearly absent disease? Eur J Pediatr. 2021;180(6):1969–1973. doi:10.1007/s00431-021-03968-6
   PubMed Web of Science ®Google Scholar
• Vittucci AC, Piccioni L, Coltella L, et al. The Disappearance of Respiratory Viruses in Children during the COVID-19 Pandemic. Int J Environ Res Public Health. 2021;18(18):9550. doi:10.3390/ijerph18189550
   PubMed Web of Science ®Google Scholar
• Nenna R, Matera L, Pierangeli A, et al. First COVID-19 lockdown resulted in most respiratory viruses disappearing among hospitalised children, with the exception of rhinoviruses. Acta Paediatr. 2022;111(7):1399–1403. doi:10.1111/apa.16326
   PubMed Web of Science ®Google Scholar
• Coma E, Vila J, Mendez-Boo L, et al. Respiratory Syncytial Virus Infections in Young Children Presenting to Primary Care in Catalonia During the COVID-19 Pandemic. J Pediatric Infect Dis Soc. 2022;11(2):69–72. doi:10.1093/jpids/piab121
   PubMed Web of Science ®Google Scholar
• Reyes Dominguez AI, Pavlovic Nesic S, Urquia Marti L, Reyes Suarez D, Garcia-Munoz Rodrigo F. Effects of public health measures during the SARS-CoV-2 pandemic on the winter respiratory syncytial virus epidemic: an interrupted time series analysis. Paediatr Perinat Epidemiol. 2022;36(3):329–336. doi:10.1111/ppe.12829
   PubMed Web of Science ®Google Scholar
• Torres-Fernandez D, Casellas A, Mellado MJ, Calvo C, Bassat Q. Acute bronchiolitis and respiratory syncytial virus seasonal transmission during the COVID-19 pandemic in Spain: a national perspective from the pediatric Spanish Society (AEP). J Clin Virol. 2021;145:105027. doi:10.1016/j.jcv.2021.105027
   PubMed Web of Science ®Google Scholar
• Delestrain C, Danis K, Hau I, et al. Impact of COVID-19 social distancing on viral infection in France: a delayed outbreak of RSV. Pediatr Pulmonol. 2021;56(12):3669–3673. doi:10.1002/ppul.25644
   PubMed Web of Science ®Google Scholar
• Stamm P, Sagoschen I, Weise K, et al. Influenza and RSV incidence during COVID-19 pandemic-an observational study from in-hospital point-of-care testing. Med Microbiol Immunol. 2021;210(5–6):277–282. doi:10.1007/s00430-021-00720-7
   PubMed Web of Science ®Google Scholar
• Engels G, Sack J, Weissbrich B, et al. Very Low Incidence of SARS-CoV-2, Influenza and RSV but High Incidence of Rhino-, Adeno- and Endemic Coronaviruses in Children With Acute Respiratory Infection in Primary Care Pediatric Practices During the Second and Third Wave of the SARS-CoV-2 Pandemic. Pediatr Infect Dis J. 2022;41(4):e146–e148. doi:10.1097/INF.0000000000003460
   PubMed Web of Science ®Google Scholar
• Kuitunen I, Artama M, Makela L, Backman K, Heiskanen-Kosma T, Renko M. Effect of Social Distancing Due to the COVID-19 Pandemic on the Incidence of Viral Respiratory Tract Infections in Children in Finland During Early 2020. Pediatr Infect Dis J. 2020;39(12):e423–e427. doi:10.1097/INF.0000000000002845
   PubMed Web of Science ®Google Scholar
• Kuitunen I, Renko M. Lessons to learn from the current pandemic for future non-pharmaceutical interventions against the respiratory syncytial virus - nationwide register-study in Finland. Infect Dis. 2021;53(6):476–478. doi:10.1080/23744235.2021.1894351
   PubMed Web of Science ®Google Scholar
• Yeoh DK, Foley DA, Minney-Smith CA, et al. Impact of Coronavirus Disease 2019 Public Health Measures on Detections of Influenza and Respiratory Syncytial Virus in Children During the 2020 Australian Winter. Clin Infect Dis. 2021;72(12):2199–2202. doi:10.1093/cid/ciaa1475
   PubMed Web of Science ®Google Scholar
• El-Heneidy A, Ware RS, Robson JM, Cherian SG, Lambert SB, Grimwood K. Respiratory virus detection during the COVID-19 pandemic in Queensland, Australia. Aust N Z J Public Health. 2022;46(1):10–15. doi:10.1111/1753-6405.13168
   PubMed Web of Science ®Google Scholar
• Abo YN, Clifford V, Lee LY, et al. COVID-19 public health measures and respiratory viruses in children in Melbourne. J Paediatr Child Health. 2021;57(12):1886–1892. doi:10.1111/jpc.15601
   PubMed Web of Science ®Google Scholar
• Britton PN, Hu N, Saravanos G, et al. COVID-19 public health measures and respiratory syncytial virus. Lancet Child Adolesc Health. 2020;4(11):e42–e43. doi:10.1016/S2352-4642(20)30307-2
   PubMedGoogle Scholar
• Tempia S, Walaza S, Bhiman JN, et al. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 2021;26(29). doi:10.2807/1560-7917.ES.2021.26.29.2001600
   PubMedGoogle Scholar
• Trenholme A, Webb R, Lawrence S, et al. COVID-19 and Infant Hospitalizations for Seasonal Respiratory Virus Infections, New Zealand, 2020. Emerg Infect Dis. 2021;27(2):641–643. doi:10.3201/eid2702.204041
   PubMed Web of Science ®Google Scholar
• Huang QS, Wood T, Jelley L, et al. Impact of the COVID-19 non pharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun. 2021;12(1):1001. doi:10.1038/s41467-021-21157-9
   PubMed Web of Science ®Google Scholar
• Maruo Y, Ishikawa S, Oura K, et al. The impact of the coronavirus disease 2019 pandemic on pediatric hospitalization in Kitami, Japan. Pediatr Int. 2022;64(1):e14937. doi:10.1111/ped.14937
   PubMed Web of Science ®Google Scholar
• Wagatsuma K, Koolhof IS, Shobugawa Y, Saito R. Decreased human respiratory syncytial virus activity during the COVID-19 pandemic in Japan: an ecological time-series analysis. BMC Infect Dis. 2021;21(1):734. doi:10.1186/s12879-021-06461-5
   PubMed Web of Science ®Google Scholar
• Kim JH, Roh YH, Ahn JG, et al. Respiratory syncytial virus and influenza epidemics disappearance in Korea during the 2020-2021 season of COVID-19. Int J Infect Dis. 2021;110:29–35. doi:10.1016/j.ijid.2021.07.005
   PubMed Web of Science ®Google Scholar
• Park S, Michelow IC, Choe YJ. Shifting Patterns of Respiratory Virus Activity Following Social Distancing Measures for Coronavirus Disease 2019 in South Korea. J Infect Dis. 2021;224(11):1900–1906. doi:10.1093/infdis/jiab231
   PubMed Web of Science ®Google Scholar
• Lee CY, Wu TH, Fang YP, et al. Delayed respiratory syncytial virus outbreak in 2020 in Taiwan was correlated with two novel RSV-A genotype ON1 variants. Influenza Other Respi Viruses. 2022;16(3):511–520. doi:10.1111/irv.12951
   PubMed Web of Science ®Google Scholar
• Chiu SS, Cowling BJ, Peiris JSM, Chan ELY, Wong WHS, Lee KP. Effects of Non pharmaceutical COVID-19 Interventions on Pediatric Hospitalizations for Other Respiratory Virus Infections, Hong Kong. Emerg Infect Dis. 2022;28(1):62–68. doi:10.3201/eid2801.211099
   PubMed Web of Science ®Google Scholar
• Bhardwaj S, Choudhary ML, Jadhav S, et al. A retrospective analysis of respiratory virus transmission before and during the COVID-19 pandemic in Pune the western region of India. Front Public Health. 2022;10:936634. doi:10.3389/fpubh.2022.936634
   PubMed Web of Science ®Google Scholar
• Rana MS, Usman M, Alam MM, et al. Impact of COVID-19 preventive measures on other infectious and non-infectious respiratory diseases in Pakistan. J Infect. 2021;82(5):e31–e32. doi:10.1016/j.jinf.2021.01.018
   PubMed Web of Science ®Google Scholar
• Letafati A, Aghamirmohammadali FS, Rahimi-Foroushani A, Hasani SA, Mokhtari-Azad T, Yavarian J. No human respiratory syncytial virus but SARS-CoV-2 found in children under 5 years old referred to Children Medical Center in 2021, Tehran, Iran. J Med Virol. 2022;94(7):3096–3100. doi:10.1002/jmv.27685
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li W, Yang B, et al. Epidemiological and virological characteristics of respiratory tract infections in children during COVID-19 outbreak. BMC Pediatr. 2021;21(1):195. doi:10.1186/s12887-021-02654-8
   PubMed Web of Science ®Google Scholar
• Du X, Wu G, Zhu Y, Zhang S. Exploring the epidemiological changes of common respiratory viruses since the COVID-19 pandemic: a hospital study in Hangzhou, China. Arch Virol. 2021;166(11):3085–3092. doi:10.1007/s00705-021-05214-8
   PubMed Web of Science ®Google Scholar
• Li L, Wang H, Liu A, et al. Comparison of 11 respiratory pathogens among hospitalized children before and during the COVID-19 epidemic in Shenzhen, China. Virol J. 2021;18(1):202. doi:10.1186/s12985-021-01669-y
   PubMed Web of Science ®Google Scholar
• Ye Q, Liu H. Impact of non-pharmaceutical interventions during the COVID-19 pandemic on common childhood respiratory viruses - An epidemiological study based on hospital data. Microbes Infect. 2022;24(1):104911. doi:10.1016/j.micinf.2021.104911
   PubMed Web of Science ®Google Scholar
• Liu P, Xu M, Lu L, et al. The changing pattern of common respiratory and enteric viruses among outpatient children in Shanghai, China: two years of the COVID-19 pandemic. J Med Virol. 2022;94(10):4696–4703. doi:10.1002/jmv.27896
   PubMed Web of Science ®Google Scholar
• Leuzinger K, Roloff T, Gosert R, et al. Epidemiology of SARS-CoV-2 Emergence Amidst Community-Acquired Respiratory Viruses. medRxiv. 2020. doi:10.1101/2020.07.07.20148163
   Google Scholar
• Nenna R, Matera L, Licari A, et al. An Italian Multicenter Study on the Epidemiology of Respiratory Syncytial Virus During SARS-CoV-2 Pandemic in Hospitalized Children. Front Pediatr. 2022;10:930281. doi:10.3389/fped.2022.930281
   PubMed Web of Science ®Google Scholar
• Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA. 2020;323(20):2085–2086. doi:10.1001/jama.2020.6266
   PubMed Web of Science ®Google Scholar
• Baker RE, Park SW, Yang W, Vecchi GA, Metcalf CJE, Grenfell BT. The impact of COVID-19 non pharmaceutical interventions on the future dynamics of endemic infections. Proce National Acad Sci. 2020;117(48):30547–30553. doi:10.1073/pnas.2013182117
   PubMed Web of Science ®Google Scholar
• Li Y, Wang X, Msosa T, de Wit F, Murdock J, Nair H. The impact of the 2009 influenza pandemic on the seasonality of human respiratory syncytial virus: a systematic analysis. Influenza Other Respir Viruses. 2021;15(6):804–812. doi:10.1111/irv.12884
   PubMed Web of Science ®Google Scholar
• Madaniyazi L, Seposo X, Ng CFS, et al. Respiratory Syncytial Virus Outbreaks Are Predicted after the COVID-19 Pandemic in Tokyo, Japan. Jpn J Infect Dis. 2022;75(2):209–211. doi:10.7883/yoken.JJID.2021.312
   PubMed Web of Science ®Google Scholar
• Baker RE, Park SW, Yang W, Vecchi GA, Metcalf CJE, Grenfell BT. The impact of COVID-19 non pharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci U S A. 2020;117(48):30547–30553. doi:10.1073/pnas.2013182117
   PubMed Web of Science ®Google Scholar
• Cooney HC, Fleming C, Scheffer IE. Respiratory syncytial virus epidemic during the COVID-19 pandemic. J Paediatr Child Health. 2022;58(1):215–216. doi:10.1111/jpc.15847
   PubMed Web of Science ®Google Scholar
• Perez A, Lively JY, Curns A, et al. Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses - New Vaccine Surveillance Network, United States, 2016-2021. MMWR Morb Mortal Wkly Rep. 2022;71(40):1253–1259. doi:10.15585/mmwr.mm7140a1
   PubMed Web of Science ®Google Scholar
• Foley DA, Phuong LK, Peplinski J, et al. Examining the interseasonal resurgence of respiratory syncytial virus in Western Australia. Arch Dis Child. 2022;107(3):e7. doi:10.1136/archdischild-2021-322507
   PubMed Web of Science ®Google Scholar
• Foley DA, Yeoh DK, Minney-Smith CA, et al. The Interseasonal Resurgence of Respiratory Syncytial Virus in Australian Children Following the Reduction of Coronavirus Disease 2019-Related Public Health Measures. Clin Infect Dis. 2021;73(9):e2829–e2830. doi:10.1093/cid/ciaa1906
   PubMedGoogle Scholar
• Agha R, Avner JR. Delayed Seasonal RSV Surge Observed During the COVID-19 Pandemic. Pediatrics. 2021;148(3). doi:10.1542/peds.2021-052089
   PubMed Web of Science ®Google Scholar
• von Hammerstein AL, Aebi C, Barbey F, et al. Interseasonal RSV infections in Switzerland - rapid establishment of a clinician-led national reporting system (RSV EpiCH). Swiss Med Wkly. 2021;151:w30057. doi:10.4414/SMW.2021.w30057
   PubMed Web of Science ®Google Scholar
• Cai W, Durrwald R, Biere B, et al. Determination of respiratory syncytial virus epidemic seasons by using 95% confidence interval of positivity rates, 2011-2021, Germany. Influenza Other Respir Viruses. 2022;16(5):854–857. doi:10.1111/irv.12996
   PubMed Web of Science ®Google Scholar
• Loconsole D, Centrone F, Rizzo C, et al. Out-of-Season Epidemic of Respiratory Syncytial Virus during the COVID-19 Pandemic: the High Burden of Child Hospitalization in an Academic Hospital in Southern Italy in 2021. Children. 2022;9(6):Jun. doi:10.3390/children9060848
   Google Scholar
• Kuitunen I, Artama M, Haapanen M, Renko M. Respiratory virus circulation in children after relaxation of COVID-19 restrictions in fall 2021-A nationwide register study in Finland. J Med Virol. 2022;94(9):4528–4532. doi:10.1002/jmv.27857
   PubMed Web of Science ®Google Scholar
• Moro G, Mamo C. 2021 EIP abstract book. Cogent Med. 2021;8(1):2002558. doi:10.1080/2331205X.2021.2002558
   Google Scholar
• Sberna G, Lalle E, Valli MB, Bordi L, Garbuglia AR, Amendola A. Changes in the Circulation of Common Respiratory Pathogens among Hospitalized Patients with Influenza-like Illnesses in the Lazio Region (Italy) during Fall Season of the Past Three Years. Int J Environ Res Public Health. 2022;19(10):5962. doi:10.3390/ijerph19105962
   PubMed Web of Science ®Google Scholar
• Ujiie M, Tsuzuki S, Nakamoto T, Iwamoto N. Resurgence of Respiratory Syncytial Virus I nfections during COVID-19 Pandemic, Tokyo, Japan. Emerg Infect Dis. 2021;27(11):2969–2970. doi:10.3201/eid2711.211565
   PubMed Web of Science ®Google Scholar
• Mohebi L, Karami H, Mirsalehi N, et al. A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: an unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022. J Med Virol. 2022;94(12):5802–5807. doi:10.1002/jmv.28065
   PubMed Web of Science ®Google Scholar
• Billard M-N, van de Ven PM, Baraldi B, Kragten-Tabatabaie L, Bont LJ, Wildenbeest JG. International changes in respiratory syncytial virus (RSV) epidemiology during the COVID-19 pandemic: association with school closures. Influenza Other Respi Viruses. 2022;16(5):926–936. doi:10.1111/irv.12998
   PubMed Web of Science ®Google Scholar
• Binns E, Koenraads M, Hristeva L, et al. Influenza and respiratory syncytial virus during the COVID-19 pandemic: time for a new paradigm? Pediatr Pulmonol. 2022;57(1):38–42. doi:10.1002/ppul.25719
   PubMed Web of Science ®Google Scholar
• Casalegno J, Javouhey E, Ploin D, et al. Delayed Start of the Respiratory Syncytial Virus Epidemic at the End of the 20/21 Northern Hemisphere Winter Season, Lyon, France. medRxiv. 2021. doi:10.1101/2021.03.12.21253446
   Google Scholar
• van Summeren J, Meijer A, Aspelund G, et al. Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter? Euro Surveill. 2021;26(29). doi:10.2807/1560-7917.ES.2021.26.29.2100639
   PubMedGoogle Scholar
• Di Mattia G, Nenna R, Mancino E, et al. During the COVID-19 pandemic where has respiratory syncytial virus gone? Pediatr Pulmonol. 2021;56(10):3106–3109. doi:10.1002/ppul.25582
   PubMed Web of Science ®Google Scholar
• Cohen R, Ashman M, Taha MK, et al. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infect Dis Now. 2021;51(5):418–423. doi:10.1016/j.idnow.2021.05.004
   PubMedGoogle Scholar
• Reicherz F, Xu RY, Abu-Raya B, et al. Waning immunity against respiratory syncytial virus during the COVID-19 pandemic. J Infect Dis. 2022;226(12):2064–2068. doi:10.1093/infdis/jiac192
   PubMed Web of Science ®Google Scholar
• Hatter L, Eathorne A, Hills T, Bruce P, Beasley R. Respiratory syncytial virus: paying the immunity debt with interest. Lancet Child Adolesc Health. 2021;5(12):e44–e45. doi:10.1016/S2352-4642(21)00333-3
   PubMedGoogle Scholar
• Emanuels A, Heimonen J, O’Hanlon J, et al. Remote household observation for noninfluenza respiratory viral illness. Clin Infect Dis. 2021;73(11):e4411–e4418. doi:10.1093/cid/ciaa1719
   PubMed Web of Science ®Google Scholar
• Pappa S, Haidopoulou K, Zarras C, et al. Early initiation of the respiratory syncytial virus season in 2021-2022, Greece. J Med Virol. 2022;94(7):3453–3456. doi:10.1002/jmv.27671
   PubMed Web of Science ®Google Scholar
• Eden JS, Sikazwe C, Xie R, et al. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions. Nat Commun. 2022;13(1):2884. doi:10.1038/s41467-022-30485-3
   PubMed Web of Science ®Google Scholar
• Baier C, Huang J, Reumann K, et al. Target capture sequencing reveals a monoclonal outbreak of respiratory syncytial virus B infections among adult hematologic patients. Antimicrob Resist Infect Control. 2022;11(1):88. doi:10.1186/s13756-022-01120-z
   PubMed Web of Science ®Google Scholar
• Kahanowitch R, Gaviria S, Aguilar H, et al. How did respiratory syncytial virus and other pediatric respiratory viruses change during the COVID-19 pandemic? Pediatr Pulmonol. 2022;57(10):2542–2545. doi:10.1002/ppul.26053
   PubMed Web of Science ®Google Scholar
• Kuchar E, Zaleski A, Wronowski M, et al. Children were less frequently infected with SARS-CoV-2 than adults during 2020 COVID-19 pandemic in Warsaw, Poland. Eur J Clin Microbiol Infect Dis. 2021;40(3):541–547. doi:10.1007/s10096-020-04038-9
   PubMed Web of Science ®Google Scholar
• Swets MC, Russell CD, Harrison EM, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet. 2022;399(10334):1463–1464. doi:10.1016/S0140-6736(22)00383-X
   PubMed Web of Science ®Google Scholar
• Cong B, Deng S, Wang X, Li Y. The role of respiratory co-infection with influenza or respiratory syncytial virus in the clinical severity of COVID-19 patients: a systematic review and meta-analysis. J Glob Health. 2022;12:05040. doi:10.7189/jogh.12.05040
   PubMed Web of Science ®Google Scholar
• Alvares PA. SARS-CoV-2 and Respiratory Syncytial Virus Coinfection in Hospitalized Pediatric Patients. Pediatr Infect Dis J. 2021;40(4):e164–e166. doi:10.1097/INF.0000000000003057
   PubMed Web of Science ®Google Scholar
• Hashemi SA, Safamanesh S, Ghasemzadeh-Moghaddam H, Ghafouri M, Azimian A. High prevalence of SARS-CoV-2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran. J Med Virol. 2021;93(2):1008–1012. doi:10.1002/jmv.26364
   PubMed Web of Science ®Google Scholar
• Hedberg P, Johansson N, Ternhag A, Abdel-Halim L, Hedlund J, Naucler P. Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus. BMC Infect Dis. 2022;22(1):108. doi:10.1186/s12879-022-07089-9
   PubMed Web of Science ®Google Scholar
• Borchers AT, Chang C, Gershwin ME, Gershwin LJ. Respiratory syncytial virus--a comprehensive review. Clin Rev Allergy Immunol. 2013;45(3):331–379. doi:10.1007/s12016-013-8368-9
   PubMed Web of Science ®Google Scholar
• Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis. 2004;189(2):233–238. doi:10.1086/380907
   PubMed Web of Science ®Google Scholar
• Manzoni P, Figueras-Aloy J, Simoes EAF, et al. Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases. Infect Dis Ther. 2017;6(3):383–411. doi:10.1007/s40121-017-0160-3
   PubMed Web of Science ®Google Scholar
• Miller JM, Binnicker MJ, Campbell S, et al. A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018;67(6):e1–e94. doi:10.1093/cid/ciy381
   PubMed Web of Science ®Google Scholar
• Kim SH, AlMutawa F. Tracheal Aspirate and Bronchoalveolar Lavage as Potential Specimen Types for COVID-19 Testing Using the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV. Microbiol Spectr. 2022;10(3):e0039922. doi:10.1128/spectrum.00399-22
   PubMed Web of Science ®Google Scholar
• Teirlinck AC, Broberg EK, Stuwitz Berg A, et al. Recommendations for respiratory syncytial virus surveillance at the national level. Eur Respir J. 2021;58(3):2003766. doi:10.1183/13993003.03766-2020
   PubMed Web of Science ®Google Scholar
• Mostafa HH, Carroll KC, Hicken R, et al. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test. J Clin Microbiol. 2021;59(3):e02955–20. doi:10.1128/JCM.02955-20
   PubMed Web of Science ®Google Scholar
• Wolters F, Grunberg M, Huber M, et al. European multicenter evaluation of Xpert(R) Xpress SARS-CoV-2/Flu/RSV test. J Med Virol. 2021;93(10):5798–5804. doi:10.1002/jmv.27111
   PubMed Web of Science ®Google Scholar
• Leung EC, Chow VC, Lee MK, Tang KP, Li DK, Lai RW. Evaluation of the Xpert Xpress SARS-CoV-2/Flu/RSV Assay for Simultaneous Detection of SARS-CoV-2, Influenza A and B Viruses, and Respiratory Syncytial Virus in Nasopharyngeal Specimens. J Clin Microbiol. 2021;59(4). doi:10.1128/jcm.02965-20
   Web of Science ®Google Scholar
• Quinton M, Geahr M, Gluck L, Jarrett J, Mostafa HH. Evaluation of the respiratory NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage and Alinity m Resp-4-Plex assays. J Clin Virol. 2022;150-151:105164. doi:10.1016/j.jcv.2022.105164
   PubMed Web of Science ®Google Scholar
• Yun J, Park JH, Kim N, et al. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs. J Korean Med Sci. 2021;36(48):e328. doi:10.3346/jkms.2021.36.e328
   PubMed Web of Science ®Google Scholar
• Phan T, Tran NYK, Gottlieb T, Siarakas S, McKew G. Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput. Pathology. 2022;54(4):466–471. doi:10.1016/j.pathol.2022.02.002
   PubMed Web of Science ®Google Scholar
• Larkin HD. First Nonprescription COVID-19 Test That Also Detects Flu and RSV. JAMA. 2022;328(1):11. doi:10.1001/jama.2022.11031
   Web of Science ®Google Scholar
• Kim TY, Kim JY, Shim HJ, et al. Comparison of the PowerChek SARS-CoV-2, Influenza A&B, RSV Multiplex Real-time PCR Kit and BioFire Respiratory Panel 2.1 for simultaneous detection of SARS-CoV-2, influenza A and B, and respiratory syncytial virus. J Virol Methods. 2021;298:114304. doi:10.1016/j.jviromet.2021.114304
   PubMed Web of Science ®Google Scholar
• Beaird OE, Freifeld A, Ison MG, et al. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative. Transpl Infect Dis. 2016;18(2):210–215. doi:10.1111/tid.12510
   PubMed Web of Science ®Google Scholar
• Hirsch HH, Martino R, Ward KN, Boeckh M, Einsele H, Ljungman P. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis. 2013;56(2):258–266. doi:10.1093/cid/cis844
   PubMed Web of Science ®Google Scholar
• Ventre K, Randolph A. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev. 2004;(4):CD000181. doi:10.1002/14651858.CD000181.pub2
   PubMedGoogle Scholar
• Gorcea CM, Tholouli E, Turner A, et al. Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipients. J Hosp Infect. 2017;95(2):214–217. doi:10.1016/j.jhin.2016.11.012
   PubMed Web of Science ®Google Scholar
• Shah JN, Chemaly RF. Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood. 2011;117(10):2755–2763. doi:10.1182/blood-2010-08-263400
   PubMed Web of Science ®Google Scholar
• Sinclair SM, Jones JK, Miller RK, Greene MF, Kwo PY, Maddrey WC. The Ribavirin Pregnancy Registry: an Interim Analysis of Potential Teratogenicity at the Mid-Point of Enrollment. Drug Saf. 2017;40(12):1205–1218. doi:10.1007/s40264-017-0566-6
   PubMed Web of Science ®Google Scholar
• Ottolini MG, Porter DD, Hemming VG, Zimmerman MN, Schwab NM, Prince GA. Effectiveness of RSVIG prophylaxis and therapy of respiratory syncytial virus in an immunosuppressed animal model. Bone Marrow Transplant. 1999;24(1):41–45. doi:10.1038/sj.bmt.1701813
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics Committee on Infectious D, American Academy of Pediatrics Bronchiolitis Guidelines C. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014;134(2):e620–38. doi:10.1542/peds.2014-1666
   PubMedGoogle Scholar
• Villanueva DH, Arcega V, Rao M. Review of respiratory syncytial virus infection among older adults and transplant recipients. Ther Adv Infect Dis. 2022;9:20499361221091413. doi:10.1177/20499361221091413
   Web of Science ®Google Scholar
• Boeckh M, Berrey MM, Bowden RA, Crawford SW, Balsley J, Phase CL. 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. J Infect Dis. 2001;184(3):350–354. doi:10.1086/322043
   PubMed Web of Science ®Google Scholar
• Permpalung N, Mahoney MV, McCoy C, et al. Clinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)-infected hematologic malignancy and hematopoietic stem cell transplant recipients receiving palivizumab. Leuk Lymphoma. 2019;60(1):85–91. doi:10.1080/10428194.2018.1468896
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Updated Guidance: use of Palivizumab Prophylaxis to Prevent Hospitalization From Severe Respiratory Syncytial Virus Infection During the 2022-2023 RSV Season. Available from: https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/interim-guidance-for-use-of-palivizumab-prophylaxis-to-prevent-hospitalization/. Accessed January 18, 2023.
   Google Scholar
• Taylor RS. Respiratory syncytial virus and palivizumab prophylaxis in the COVID-19 era. CMAJ. 2021;193(15):E523. doi:10.1503/cmaj.78240
   PubMed Web of Science ®Google Scholar
• Tripp RA, Stambas J. Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins. Viruses. 2021;13(4):Apr. doi:10.3390/v13040625
   Web of Science ®Google Scholar
• Lambkin-Williams R, DeVincenzo JP. A COVID-19 human viral challenge model. Learning from experience. Influenza Other Respir Viruses. 2020;14(6):747–756. doi:10.1111/irv.12797
   PubMed Web of Science ®Google Scholar
• Zhen W, Manji R, Smith E, Wuitschick J, Lucic D, Berry GJ. Evaluation of the Alinity m Resp-4-Plex Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2, Influenza A Virus, Influenza B Virus, and Respiratory Syncytial Virus. Microbiol Spectr. 2022;10(1):e0109021. doi:10.1128/spectrum.01090-21
   PubMed Web of Science ®Google Scholar
• Cheng A, Riedel S, Arnaout R, Kirby JE. Verification of the Abbott Alinity m Resp-4-Plex assay for detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus. Diagn Microbiol Infect Dis. 2022;102(2):115575. doi:10.1016/j.diagmicrobio.2021.115575
   PubMed Web of Science ®Google Scholar
• Sahajpal NS, Mondal AK, Ananth S, et al. Clinical validation of a multiplex PCR-based detection assay using saliva or nasopharyngeal samples for SARS-Cov-2, influenza A and B. Sci Rep. 2022;12(1):3480. doi:10.1038/s41598-022-07152-0
   PubMed Web of Science ®Google Scholar
• Prevention CfDCa. Table 4. Multiplex Assays Authorized for Simultaneous Detection of Influenza Viruses and SARS-CoV-2 by FDA. Accessed October 10, 2022. Available from: https://www.cdc.gov/flu/professionals/diagnosis/table-flu-covid19-detection.html.
   Google Scholar
• Administration USFaD. In vitro diagnostics EUAs - Molecular Diagnostic Tests for SARS-CoV-2. Available from: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/in-vitro-diagnostics-euas-molecular-diagnostic-tests-sars-cov-2#individual-molecular. Accessed Oct 10, 2022.
   Google Scholar
• Lim HJ, Park JE, Park MY, et al. Assay System for Simultaneous Detection of SARS-CoV-2 and Other Respiratory Viruses. Diagnostics. 2021;11(6):548. doi:10.3390/diagnostics11061084
   Web of Science ®Google Scholar
• Neopane P, Nypaver J, Shrestha R, Beqaj S. Performance Evaluation of TaqMan SARS-CoV-2, Flu A/B, RSV RT-PCR Multiplex Assay for the Detection of Respiratory Viruses. Infect Drug Resist. 2022;15:5411–5423. doi:10.2147/IDR.S373748
   PubMed Web of Science ®Google Scholar
• Mboumba Bouassa RS, Tonen-Wolyec S, Veyer D, Pere H, Belec L. Analytical performances of the AMPLIQUICK(R) Respiratory Triplex assay for simultaneous detection and differentiation of SARS-CoV-2, influenza A/B and respiratory syncytial viruses in respiratory specimens. PLoS One. 2022;17(1):e0262258. doi:10.1371/journal.pone.0262258
   PubMed Web of Science ®Google Scholar
• Chung HY, Jian MJ, Chang CK, et al. Multicenter study evaluating one multiplex RT-PCR assay to detect SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the LabTurbo AIO open platform: epidemiological features, automated sample-to-result, and high-throughput testing. Aging. 2021;13(23):24931–24942. doi:10.18632/aging.203761
   PubMedGoogle Scholar